š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This is a prospective, multicenter, open-label, randomized, controlled Stud...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07417241
Treatments Being Tested
Trastuzumab resistance, which is a common therapeutic challenge in HER2 pos...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2019-06-26
Trial ID
NCT04001621
Treatments Being Tested
Given that pyrotinib has been proven to exert significant efficacy against ...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2026-07-06
Trial ID
NCT07600164
Treatments Being Tested
Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER-1 and HER...
Status
Unknown
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2015-05
Trial ID
NCT02422199
Treatments Being Tested
To evaluate the efficacy of continuation targeted therapy compared with tra...
Status
Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2021-07-02
Trial ID
NCT05292742
Treatments Being Tested
Dynamic observationaL study with PET of 68Ga-HER2-affibody in anti-HER2 tre...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-02-18
Trial ID
NCT04769050
This is an open, prospective and interventional clinical study. Patients wi...
Status
Unknown
Location
The First Affiliated Hospital of Xi'an Jiaotong University
Start Date
2021-01-01
Trial ID
NCT05429684
This is a retrospective, single-arm real-world study based on the National ...
Status
Unknown
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2023-02-01
Trial ID
NCT06481553
Treatments Being Tested
The prognosis of young patients with breast cancer is relatively poor. Chem...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Start Date
2023-08-01
Trial ID
NCT06027541
Treatments Being Tested
Objective: To explore the efficacy and safety of Pyrotinib, trastuzumab sub...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07-15
Trial ID
NCT06483386
Treatments Being Tested